Nanoscope Therapeutics Inc., a US-based clinical-stage biotechnology company, announced on Monday that it has named Vicente Anido Jr, PhD as its new strategic advisor to the company's board and management.
Dr Anido Jr has more than three decades of ophthalmic experience. He has served as chief executive officer and chairman at Aerie Pharmaceuticals. He has worked in various companies including his role as chief executive officer at ISTA Pharmaceuticals.
Sulagna Bhattacharya, Nanoscope Therapeutics chief executive officer and co-founder, said, 'We are pleased to have Vince join our team of advisors. His deep experience and accomplishments in building and commercialising profitable ophthalmic companies will provide valuable guidance to support our clinical and corporate strategy. We look forward to leveraging his expertise as we advance Nanoscope's platform of optogenetic therapies to restore vision in sufferers of inherited retinal degenerative diseases.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer